Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3CNS 1

Conditions

Head and Neck Neoplasms 3Radiodermatitis 1Mouth Neoplasms 1Hypotension 1Alopecia 1

Interventions

Cisplatin 620pembrolizumab 323Radiotherapy 319Cetuximab 275Docetaxel 221Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 75Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 50Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 44Standard of Care 43tislelizumab 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Norepinephrine × Head & Neck × Clear all
NCT02241083 2014-09-16

The Effect of Norepinephrine and Dopamine on Radial Forearm Free Flap Tissue Oxygen Pressure and Microdialysate Metabolite Measurements

Tampere University Hospital

Phase 4 Completed
25 enrolled
Head & Neck

Head and Neck Neoplasms

NCT01367990 2012-03-23

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

ProCertus BioPharm, Inc

Phase 1 Terminated
3 enrolled
Head & Neck

Alopecia, Head and Neck Neoplasms, Radiodermatitis

NCT01418118 2011-08-16

Free4Flow

Oxford University Hospitals NHS Trust

Phase 4 Completed
25 enrolled
Head & Neck

Head and Neck Neoplasms, Hypotension, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡